Shifting Culture & Shared Learnings: Building Community to Support Canadian Medical Oncologists

Learning Objectives

Burnout has been a long-term problem in healthcare and the demands on oncologists over the last two years have only intensified the issue.  Delayed cancer screening and subsequent presentation means Oncologists will continue to face high levels of job stress over the years to come.

Join co-chairs Dr. Sharlene Gill and Dr. Scott Berry for a 3-part webinar series. With the help of Canadian and International experts, the series will explore how to recognize burnout, build resilience and develop community.


Thursday, May 26, 2022

Local Time

  • Timezone: America/New_York
  • Date: Thursday, May 26, 2022
  • Time: 7:00 pm - 8:30 pm

Registration will be complimentary for Healthcare professionals and can be completed below. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at for registration and sponsorship opportunities.

Book Event

1 Ticket selected.

Available Tickets: Unlimited

The ticket is sold out. You can try another ticket or another date.

personAbout the Faculty

Scott Berry BSc, MD, MHSc, FRCPC


Dr. Scott Berry is a medical oncologist and Professor and Department Head in the Queen’s University Department of Oncology.  He is the Cancer Program Medical Director at the Cancer Centre of Southeastern Ontario at the Kingston Health Sciences Centre.

Dr. Berry is an active participant in clinical research in GI cancer. He is the Co-Chair of the GI Disease Site Group of the CCO Program in Evidence Based Care. 

Dr. Berry loves teaching, has won several teaching awards and is a past Chair of the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology 

His other academic interest is the bioethical issues surrounding the care of people with cancer, in particular the ethical issues surrounding funding new and expensive cancer medications. Dr. Berry has a Master’s degree in Bioethics from the University of Toronto. He is the former ethics advisor to the pan-Canadian Oncology Drug Review and has served on the ASCO Ethics Committee.


Sharlene Gill MD, MPH, MBA, FRCPC


Dr. Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver.  She received a Bachelor’s of Science in Pharmacy and an MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Master’s of Public Health from the Harvard School of Public Health. In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina.  She is actively engaged in education and research, with over 100 peer-reviewed publications and book chapters to her credit.  Dr. Gill currently serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee, and is President-Elect for the Canadian Association of Medical Oncologists.

Panel Discussion


Dr. Christine Simmons
Dr. Stephen Welch
Dr. Kara Laing
Dr. Lacey Pitre
Dr. Elie Kassouf



Ipsen Logo
Merck Logo
Pfizer Logo